Clinical outcomes of treatment of anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis...
Clinical outcomes of treatment of anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis based on ANCA type
About this item
Full title
Author / Creator
Unizony, Sebastian , Villarreal, Miguel , Miloslavsky, Eli M , Lu, Na , Merkel, Peter A , Spiera, Robert , Seo, Philip , Langford, Carol A , Hoffman, Gary S , Kallenberg, CG M , St. Clair, E William , Ikle, David , Tchao, Nadia K , Ding, Linna , Brunetta, Paul , Choi, Hyon K , Monach, Paul A , Fervenza, Fernando , Stone, John H , Specks, Ulrich and RAVE-ITN Research Group
Publisher
United States: Elsevier Limited
Journal title
Language
English
Formats
Publication information
Publisher
United States: Elsevier Limited
Subjects
More information
Scope and Contents
Contents
ObjectiveTo evaluate whether the classification of patients with anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) according to ANCA type (anti-proteinase 3 (PR3) or anti-myeloperoxidase (MPO) antibodies) predicts treatment response.MethodsTreatment responses were assessed among patients enrolled in the Rituximab in ANCA-assoc...
Alternative Titles
Full title
Clinical outcomes of treatment of anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis based on ANCA type
Authors, Artists and Contributors
Author / Creator
Villarreal, Miguel
Miloslavsky, Eli M
Lu, Na
Merkel, Peter A
Spiera, Robert
Seo, Philip
Langford, Carol A
Hoffman, Gary S
Kallenberg, CG M
St. Clair, E William
Ikle, David
Tchao, Nadia K
Ding, Linna
Brunetta, Paul
Choi, Hyon K
Monach, Paul A
Fervenza, Fernando
Stone, John H
Specks, Ulrich
RAVE-ITN Research Group
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4908815
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4908815
Other Identifiers
ISSN
0003-4967
E-ISSN
1468-2060
DOI
10.1136/annrheumdis-2015-208073
